Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical and endoscopic remission in Crohn’s disease and ulcerative colitis – experiences from a single center
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Milassin, Anna Fábián, Zoltán Szepes, Tamás Molnár
január, 2016